EirGen Pharma Product EIR-050 Launches in Mexico

EirGen Pharma Product EIR-050 Launches in Mexico

31 Mar

EirGen Pharma are pleased to announce that oncology molecule “Eir-050” has successfully launched in Mexico. This product was developed for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer.